Physicians' beliefs about effectiveness of cancer screening tests: A national survey of family physicians, general internists, and obstetrician-gynecologists

Preventive Medicine

Volumn 69, Issue , 2014, Pages 37-42

  Miller, Jacqueline W ^a   Baldwin, Laura Mae ^b   Matthews, Barbara ^b   Trivers, Katrina F ^a   Andrilla, C Holly ^b   Lishner, Denise ^b   Goff, Barbara A ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer screening; Cervical cancer; Colorectal cancer; Ovarian cancer; Physician beliefs

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COLONOSCOPY; COLORECTAL CANCER; FEMALE; GENERAL PRACTITIONER; GYNECOLOGIST; HEALTH SURVEY; HUMAN; INTERNIST; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OBSTETRICIAN; OVARY CANCER; PHYSICIAN ATTITUDE; UTERINE CERVIX CANCER; EARLY DIAGNOSIS; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; MALE; MIDDLE AGED; PHYSICIAN; PRACTICE GUIDELINE; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ADULT; ATTITUDE OF HEALTH PERSONNEL; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 84907553799     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.07.009     Document Type: Article

References (47)

1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology ACOG practice bulletin no. 109: cervical cytology screening. Obstet. Gynecol. 2009 Dec, 114(6):1409-1420.
2. Baldwin L.M., Trivers K.F., Matthews B., et al. Ovarian cancer screening: are U.S. physicians adhering to evidence-based recommendations?. Ann. Intern. Med. 2012, 156(3):182-194.
3. Baldwin L.M., Trivers K.F., Matthews B., et al. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?. Ann. Intern. Med. 2012, 156(3):182-194.
4. Bieler G.S., Brown G.G., Williams R.L., Brogan D.J. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am. J. Epidemiol. 2010, 171(5):618-623.
5. Brennan M., Spillane A., Houssami N. The role of breast MRI in clinical practice. Aust. Fam. Physician 2009, 38(7):513-519.
6. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999 Oct 20, 282(15):1458-1465.
7. Carter J.R., Ding Z., Rose B.R. HPV infection and cervical disease: a review. Aust. N. Z. J. Obstet. Gynaecol. 2011 Apr, 51(2):103-108.
8. Clasen C.M., Vernon S.W., Mullen P.D., Jackson G.L. A survey of physician beliefs and self-reported practices concerning screening for early detection of cancer. Soc. Sci. Med. 1994, 39(6):841-849.
9. Coughlin S.S., Breslau E.S., Thompson T., Benard V.B. Physician recommendation for papanicolaou testing among U.S. women, 2000. Cancer Epidemiol. Biomarkers Prev. 2005, 14(5):1143-1148.
10. Cummings K.M., Jaen C.R., Funch D.P. Family physicians' beliefs about screening for colorectal cancer using the stool guaiac slide test. Public Health Rep. 1984, 99(3):307-312.
11. Devlin S.M., Diehr P.H., Andersen M.R., Goff B.A., Tyree P.T., Lafferty W.E. Identification of ovarian cancer symptoms in health insurance claims data. J. Women's Health 2010, 19(3):381-389.
12. Goff B.A., Mandel L.S., Drescher C.W., et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007, 109(2):221-227.
13. Goff B., Miller J.W., Matthews B., et al. Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass. Obstet. Gynecol. 2011, 118(4):854-862.
14. Goff B.A., Matthews B., Andrilla C.H.A., et al. How are symptoms of ovarian cancer managed? A study of primary care physicians. Cancer 2011, 117(19):4414-4423.
15. Goldzweig C.L., Parkerton P.H., Washington D.L., Lanto A.B., Yano E.M. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates. Am. J. Manag. Care 2004, 10(4):265-272.
16. Gorin S.S., Ashford A.R., Lantigua R., et al. Intraurban influences on physician colorectal cancer screening practices. J. Natl. Med. Assoc. 2007, 99(12):1371-1380.
17. Guessous I., Dash C., Lapin P., Doroshenk M., Smith R.A., Klabunde C.N. National colorectal cancer roundtable screening among the 65 plus task group. Colorectal cancer screening barriers and facilitators in older persons. Prev. Med. 2010, 50(1-2):3-10.
18. Han P.K., Klabunde C.N., Breen N., et al. Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med. Care 2011, 49(2):139-148.
19. Hawley S.T., Levin B., Vernon S.W. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect. Prev. 2001, 25(3):309-318.
20. Klabunde C.N., Lanier D., Nadel M.R., McLeod C., Yuan G., Vernon S.W. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am. J. Prev. Med. 2009, 37(1):8-16.
21. Lester W.T., Ashburner J.M., Grant R.W., Chueh H.C., Barry M.J., Atlas S.J. Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network. J. Am. Med. Inform. Assoc. 2009, 16(2):187-195.
22. Meissner H.I., Tiro J.A., Yabroff K.R., Haggstrom D.A., Coughlin S.S. Too much of a good thing? Physician practices and patient willingness for less frequent Pap test screening intervals. Med. Care 2010, 48(3):249-259.
23. Meissner H.I., Klabunde C.N., Han P.K., Benard V.B., Breen N. Breast cancer screening beliefs, recommendations and practices. Cancer 2011, 117(14):3101-3111.
24. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann. Intern. Med. 2005, 142(2):86-94.
25. Nadel M.R., Berkowitz Z., Klabunde C.N., Smith R.A., Coughlin S.S., White M.C. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J. Gen. Intern. Med. 2010, 25(8):833-839.
26. Najem G.R., Batuman F., Smith A.M. Papanicolaou test status among inner-city adolescent girls. Am. J. Prev. Med. 1996, 12(6):482-486.
27. Nelson H.D., Tyne K., Naik A., Bougatsos C., Chan B.K., Humphrey L. U.S. Preventive Services Task Force (USPSTF). Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 151(10):727-737. (W237-42).
28. Nichols C., Holt C.L., Shipp M., Eloubeidi M., Fouad M.N., Britt K. Physician knowledge, perceptions of barriers, and patient colorectal cancer screening practices. Am. J. Med. Qual. 2009, 24(2):116-122.
29. Palmer R.C., Chhabra D., McKinney S. Colorectal cancer screening adherence in African-American men and women 50years of age and older living in Maryland. J. Community Health 2010 Nov 24, 10.1007/s10900-010-9336-4.
30. Pellegrino E.D., Relman A.S. Professional medical associations: ethical and practical guidelines. JAMA 1999, 282(10):984-986.
31. Ramirez A.G., Wildes K.A., Napoles-Springer A., Perez-Stable E., Talavera G., Rios E. Physician gender differences in general and cancer-specific prevention attitudes and practices. J. Cancer Educ. 2009, 24(2):85-93.
32. Rauscher G.H., Hawley S.T., Earp J.A. Baseline predictors of initiation vs. maintenance of regular mammography use among rural women. Prev. Med. 2005, 40(6):822-830.
33. Ryerson A.B., Eheman C., Burton J., et al. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstet. Gynecol. 2007, 109(5):1053-1061.
34. Saraiya M., Berkowitz Z., Yabroff K.R., Wideroff L., Kobrin S., Benard V. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?. Arch. Intern. Med. 2010, 170(11):977-985.
35. Schueler K.M., Chu P.W., Smith-Bindman R. Factors associated with mammography utilization: a systematic quantitative review of the literature. J. Women's Health (Larchmt) 2008, 17(9):1477-1498.
36. Sequist T.D., Zaslavsky A.M., Marshall R., Fletcher R.H., Ayanian J.Z. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch. Intern. Med. 2009, 169(4):364-371.
37. Smith R.A., Cokkinides V., Brooks D., Saslow D., Shah M., Brawley O.W. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J. Clin. 2011, 61:8-30.
38. Teng E.J., Friedman L.C., Green C.E. Determinants of colorectal cancer screening behavior among Chinese Americans. Psychooncology 2006, 15(5):374-381.
39. Trivers K.F., Baldwin L.M., Miller J.W., et al. Reported referral for genetic counseling or BRCA 1/2 testing among us physicians. Cancer 2011, 117(23):5334-5343.
40. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(Suppl. 1):S4-S15.
41. U.S.Preventive Services Task Force Screening for ovarian cancer: recommendation statement http://www.uspreventiveservicestaskforce.org/3rduspstf/ovariancan/ovcanrs.htm.
42. U.S.Preventive Services Task Force Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 2008, 149(9):627-637.
43. U.S.Preventive Services Task Force (USPSTF) Screening for cervical cancer: recommendations and rationale. Update to 1996 Guide to Clinical Preventive Services 1996, http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm. 2nd ed.
44. Werny D.M., Saraiya M., Carrera J., Coughlin S.S., Frank E. Learning amid controversy: prostate cancer knowledge and screening practices among US medical students. J. Cancer Educ. 2008, 23(2):108-113.
45. Wong C., Berkowitz Z., Saraiya M., Wideroff L., Benard V.B. US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening. Sex. Health 2010, 7(3):338-345.
46. Yabroff K.R., Klabunde C.N., Yuan G., et al. Are physicians' recommendations for colorectal cancer screening guideline-consistent?. J. Gen. Intern. Med. 2011, 26(2):177-184.
47. Yabroff R., Zapka J., Klabunde C., et al. Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol. Biomarkers Prev. 2011, 20(12):2471-2479.